Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Equities
6990
CNE1000062J1
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
172.8 HKD | -1.26% |
|
+5.88% | +67.93% |
Jun. 21 | Sichuan Kelun-Biotech Directors Approve Full Circulation of H-Shares | MT |
Jun. 18 | Hong Kong Shares Fall on Weak Economic Data, Trade Tensions; Wuhan Youji Surges 27% in Trading Debut | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+67.93% | 4.93B | |
+15.19% | 121B | |
+19.91% | 114B | |
+8.24% | 23.61B | |
-19.80% | 20.43B | |
-16.19% | 16.55B | |
-13.45% | 16.45B | |
-44.35% | 15.59B | |
+2.13% | 13.54B | |
+66.67% | 15.19B |
- Stock Market
- Equities
- 6990 Stock
- News Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
- Kelun-Biotech Partners with Sichuan Hospital for R&D, Commercialization of Nuclear Therapy for Tumors; Shares Jump 6%